WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D4 receptor activation

Behavioural Pharmacology

Volumn 20, Issue 1, 2009, Pages 114-118

  Marona Lewicka, Danuta ^a   Nichols, David E ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

5 ht1a receptors; D4 receptors; Drug discrimination; Rat; WAY 100635

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; DOPAMINE RECEPTOR BLOCKING AGENT; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; SEROTONIN 1A AGONIST; SODIUM CHLORIDE; SONEPIPRAZOLE; 2 (4 (3,4 DIMETHYLPHENYL)PIPERAZIN 1 YLMETHYL) 1H BENZIMIDAZOLE; 2-(4-(3,4-DIMETHYLPHENYL)PIPERAZIN-1-YLMETHYL)-1H-BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; DOPAMINE 4 RECEPTOR; LY 293284; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN 1A RECEPTOR; SULFONAMIDE; TRYPTAMINE DERIVATIVE;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG MEGADOSE; FOOD; LOW DRUG DOSE; MALE; NONHUMAN; RAT; REINFORCEMENT; SPRAGUE DAWLEY RAT; STIMULUS RESPONSE; TASK PERFORMANCE; TRAINING; ANIMAL; ANIMAL BEHAVIOR; DISCRIMINATION LEARNING; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; INSTRUMENTAL CONDITIONING;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BEHAVIOR, ANIMAL; BENZIMIDAZOLES; CONDITIONING, OPERANT; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; PINDOLOL; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, DOPAMINE D4; REINFORCEMENT SCHEDULE; SULFONAMIDES; TRYPTAMINES;

EID: 61449122102     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3283242f1a     Document Type: Article

References (23)

1. Barrett JE, Gleeson S (1992). Discriminative stimulus properties of 8-OH-DPAT in pigeons: antagonism studies with putative 5-HT1A receptor antagonists BMY 7378 and NAN-190. Eur J Pharmacol 217:163-171.
2. Chemel BR, Roth BL, Armbruster B, Watts VJ, Nichols DE (2006). WAY 100635 is a potent dopamine D4 receptor agonist. Psychopharmacology (Berl) 188:244-251.
3. Dawson LA, Nguyen HQ, Smith DL, Schechter LE (2002). Effect of chronic fluoxetine and WAY 100635 treatment on serotonergic neurotransmission in the frontal cortex. J Psychopharmacol 16:145-152.
4. De Vry J, Schohe-Loop R, Heine HG, Greuel JM, Mauler F, Schmidt B, et al. (1998). Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1 A receptor agonist. J Pharmacol Exp Ther 284: 1082-1094.
5. Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, et al. (1996). Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY 100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res 73: 337-353.
6. 1A receptor agonist with high potency and selectivity. J Pharmacol Exp Ther 270: 1270-1281.
7. Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A (1995). A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY 100635. Eur J Pharmacol 281:81 -88.
8. Gommans J, Hijzen TH, Maes RA, Olivier B (2000). Two-lever drug-drug discrimination with the 5-HT1 receptor agonists flesinoxan and eltoprazine. Int J Neuropsychopharmacol 3:221 -228.
9. Khawaja XZ, Smith DL, Nawoschik SP, Zhang J, Dunlop J, Dilks DW, et al. (2006). WAY 100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system. J Neurochem 98:134-145.
10. Kleven MS, Koek W (1998). Discriminative stimulus effects of 8-hydroxy-2-(di-n-propylaminojtetralin in pigeons and rats: species similarities and differences.
11. J Pharmacol Exp Ther 284: 238-249.
12. Litchfield JT Jr, Wilcoxon F (1949). A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-112.
13. Marona-Lewicka D, Nichols DE (1994). Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan. Eur J Pharmacol 258:1-13.
14. 1A receptor agonist LY 293284 in the drug discrimination assay in rats. Psychopharmacology 172:415-421.
15. 4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI. Psychopharmacology Jul 6. [Epub ahead of print, PM: 18604600].
16. Martel JC, Leduc N, Ormiere AM, Faucillon V, Danty N, Culie C, et al. (2007). WAY 100635 has high selectivity for serotonin 5-HT(1A) versus dopamine D(4) receptors. Eur J Pharmacol 574:15-19.
17. Nakane M, Cowart MD, Hsieh GC, Miller L, Uchic ME, Chang R, et al. (2005). 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist. Neuropharmacology 49: 112-121.
18. Reissig CJ, Eckler JR, Rabin RA, Winter JC (2005). The 5-HT1A receptor and the stimulus effects of LSD in the rat. Psychopharmacology (Berl) 182:197-204.
19. 1A receptor ligands by means of in vivo animal models. Eur J Pharmacol 315:245-254.
20. Tenbrink RE, Bergh CL, Duncan JN, Harris DW, Huff RM, Lahti RA, et al. (1996). (S)-(-)-4-[4-[2-(isochroman-1 -yl)ethyl]-piperazin-1 -yl] benzenesulfonamide, a selective dopamine D4 antagonist. J Med Chem 39:2435-2437.
21. 1A receptor. Eur J Pharmacol 133:47-56.
22. 1A receptor ligands by drug discrimination. Eur J Pharmacol 333:113-122.
23. Zar J (1999). Biostatistical analysis. 4th ed. Upper Saddle River, New Jersey: Prentice-Hall. pp. 533-538. (Section 24.6).